J&J’s HIV Therapy Etravirine Shown To Have Antiviral Activity In Phase III Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Two Phase III trials found significantly more patients taking the non-nucleoside reverse transcriptase inhibitor reached undetectable viral load.